Farrell High School students are raising awareness for an important cause--donating blood for sickle cell anemia.
Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...
A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as well as treatment guidelines.
Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonist use appeared linked to lower risk for all-cause mortality among people with sickle cell ...
Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...
ANN ARBOR, Mich. (WJRT) - A Saginaw family is celebrating the new year at Mott Children's Hospital as their son, 10-year-old Elijah Dottery, continues his fight against sickle cell anemia. He was ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...
NASHVILLE, Tenn. – Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United States, most of them ...